Man fired 180 shots, shattering 150 windows, in CDC attack
NEW YORK — The man who attacked the CDC headquarters in Atlanta on Friday fired more than 180 shots into the campus and broke about 150 windows, with bullets piercing 'blast-resistant' windows and spattering glass shards into numerous rooms, according to information circulated internally at the agency.
It may take weeks or even months to replace windows and clean up the damage, Centers for Disease Control and Prevention personnel said.
A Georgia man who had blamed the COVID-19 vaccine for making him depressed and suicidal opened fire late Friday, killing a police officer. No one at CDC was injured.
The shooter was stopped by CDC security guards before driving to a nearby pharmacy and opening fire late Friday afternoon, a law enforcement official has told the AP. The official wasn't authorized to publicly discuss the investigation and spoke on condition of anonymity. The 30-year-old man, Patrick Joseph White, later died, but authorities haven't said whether he was killed by police or killed himself.
U.S. Health Secretary Robert F. Kennedy Jr. toured the CDC campus on Monday. CDC security pointed out broken windows across multiple buildings, including the main guard booth, according to a U.S. Department of Health and Human Services statement.
HHS Deputy Secretary Jim O'Neill and CDC Director Susan Monarez accompanied him, according to the statement.
Kennedy also visited the DeKalb County Police Department, where he met with the police chief. Later. He also met privately with the widow of the fallen officer, David Rose.
Monarez posted a statement on social media Friday night that said at least four CDC buildings were hit in the attack.
The extent of the damage became more clear during a weekend CDC leadership meeting. Two CDC employees who were told about what was discussed at the meeting described details to The Associated Press on condition of anonymity because they weren't authorized to reveal the information. Details also were also in an agency memo seen by an AP reporter.
Building 21, which houses Monarez's office, was hit by the largest number of bullets. CDC officials did not say if her office was hit.
CDC employees were advised to work from home this week.
Kennedy issued a statement Saturday that said 'no one should face violence while working to protect the health of others,' and that top federal health officials were 'actively supporting CDC staff.'
He did not speak to the media during his visit Monday.
A retired CDC official, Stephan Monroe, said he worried about the long-term impact the attack would have on young scientists' willingness to go to work for the government.
'I'm concerned that this is this is going to be a generational hit,' said Monroe, speaking to a reporter near the corner where a poster had been set up in honor of Rose.
Kennedy was a leader in a national anti-vaccine movement before President Donald Trump selected him to oversee federal health agencies, and has made false and misleading statements about the safety and effectiveness of about COVID-19 shots and other vaccines.
Years of false rhetoric about vaccines and public health was bound to 'take a toll on people's mental health,' and 'leads to violence,' said Tim Young, a CDC employee who retired in April.
Dr. Jerome Adams, the U.S. surgeon general during President Donald Trump's first administration, said Sunday that health leaders should appreciate the weight of their words.
'We have to understand people are listening,' Adams told 'Face the Nation' on CBS. 'When you make claims that have been proven false time and time again about safety and efficacy of vaccines, that can cause unintended consequences.'
Mike Stobbe, The Associated Press
AP reporters Alanna Durkin Richer and Charlotte Kramon contributed to this report.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
7 minutes ago
- CTV News
Bad diets, too many meds, no exercise: A look inside the latest ‘Make America Healthy Again' report
Savannah Knott hangs up her backpack for the day on the first day in her second grade classroom at Mary Carrico Catholic School, Tuesday, Aug. 12, 2025, in Knottsville, Ky. (Greg Eans/The Messenger-Inquirer via AP) WASHINGTON — A report that U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has promised will improve the health of America's children does not call on the government to make significant changes to its food or farming policies, according to a draft document obtained by The Associated Press. The 'Make America Healthy Again' strategy report is supposed to be one of Kennedy's signature achievements as the nation's health secretary, giving the government a roadmap to help its citizens lose weight, reduce chronic diseases and exercise more. Before coming to Washington, Kennedy had spent much of his career decrying the harms of chemicals sprayed on crops, prescription drugs, ultraprocessed foods, and vaccines. His coalition, then, has expected him to take bold action as the nation's top health leader. But a draft of the so-called 'MAHA' report, first reported by The New York Times Thursday night, mostly calls on the government to further study chronic diseases, bad air quality, Americans' diets and prescription drug use. The report lays out four problem areas – poor diet, chemical exposure, lack of physical activity and overuse of medications -- that are to blame for chronic diseases in the U.S. The White House has held off on publicly releasing the report, which was submitted to U.S. President Donald Trump on Tuesday. The latest report is the policy companion to a 'MAHA' report released in May, which was found to have several errors in it. White House spokesman Kush Desai refused to confirm whether the copy obtained by the Associated Press was a final version, though HHS officials have insisted the report has been finalized since Tuesday. 'President Trump pledged to Make America Healthy Again, and the Administration is committed to delivering on that pledge with Gold Standard Science,' Desai said. 'Until officially released by the White House and MAHA Commission, however, any documents purporting to be the second MAHA Report should be considered as nothing more than speculative literature.' Some in the agricultural industry had warily anticipated the report, fearing it would call for bans or investigations into the use of pesticides and herbicides that farmers in the U.S. regularly spray on crops to control weeds and enhance yields. Other farmers were concerned about how the report may target the use of corn syrup, a common sweetener, in American foods. Both products have been a central talking point in Kennedy's 'MAHA' movement, which has attracted a diverse coalition of suburban and rural moms, Trump supporters and liberals concerned about the nation's food supply. Instead, the report calls for an 'awareness' campaign to raise confidence in pesticides. Concerns from the agricultural industry waned as the report hit the president's desk, with one of Kennedy's closest advisers, Calley Means, calling for MAHA supporters to work with major farm companies on Tuesday. Means also acknowledged that the 'pace of political change' can be frustrating. 'We need to build bridges,' Means said, adding that: 'We are not going to win if the soybean farmers and the corn growers are our enemy.' Means did not respond to a request for comment on Friday. A spokesman for Kennedy also declined to comment. The report urges the National Institutes of Health – which is facing a 40 per cent cut to its budget under the Trump administration – to undertake several studies on Americans' health, including research on vaccine injury, autism, air quality, water quality, prescription drugs, and nutrition. The report also calls for changes to the foods served in schools and hospitals, something that will be hard to deliver with the Trump administration's funding cuts, said Kari Hamerschlag, the deputy director of the food and agriculture at the nonprofit Friends of the Earth. Earlier this year, the Republican-led administration wiped out US$1 billion set aside that helped food banks and schools procure food directly from local farmers. 'This is not going to transform our food and farming system,' Hamerschlag said. 'This is not going to make people healthier. They need to put resources behind their recommendations.' ___ Amanda Seitz, The Associated Press
National Post
an hour ago
- National Post
Nike co-founder Phil Knight and wife pledge record US$2B to Oregon cancer centre
PORTLAND, Ore. — Nike co-founder Phil Knight and his wife, Penny Knight, have pledged to donate US$2 billion to Oregon Health & Science University's Knight Cancer Institute, the school announced Thursday, describing it as the largest single gift to a U.S. university. Article content 'This gift is an unprecedented investment in the millions of lives burdened with cancer, especially patients and families here in Oregon,' OHSU President Shereef Elnahal said in a statement. Article content Article content The donation will help ensure patients have access to various resources, including psychological, genetic and financial counselling, symptom management, nutritional support and survivorship care, the university statement said. Article content Article content The university described it as the 'largest single donation ever made to a U.S. university, college or academic health center.' It surpasses the US$1.8 billion given by Michael Bloomberg to Johns Hopkins in 2018, described by that university at the time as the largest single contribution to a U.S. university. Article content Bloomberg also donated an additional US$1 billion to Johns Hopkins last year, covering tuition, living expenses and fees for students from families under certain income levels. Article content The magnitude of the donation will allow the Knight Cancer Institute to become a self-governed entity with its own board of directors within OHSU, the university said. Article content Article content Knight is Oregon's richest man. In 2013, he and his wife pledged US$500 million to the cancer institute if the university matched it within two years. The match was met following US$200 million in bonds from the Oregon Legislature, US$100 million from then-chair of Columbia Sportswear Gert Boyle, and donations from some 10,000 people, the university said. Article content
CTV News
2 hours ago
- CTV News
Lilly signs US$1.3 billion deal with Superluminal to discover obesity medicines using AI
A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis. (AP Photo/Darron Cummings, File) Eli Lilly has signed a deal worth US$1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other cardiometabolic diseases. Lilly currently dominates the obesity treatment market, estimated to be worth $150 billion by the next decade, and is trying to strengthen its foothold in the space through the development of next-generation drugs, acquisitions and partnerships. The deal gives Lilly exclusive rights to develop and commercialize drug candidates discovered using Superluminal's proprietary AI-driven platform targeting G-protein-coupled receptors (GPCR) - a class of proteins that can influence physiological processes including metabolism, cell growth and immune responses - the drug developer said on Thursday. Drugmakers including Danish rival Novo Nordisk are exploring potential GPCR targets to develop oral small-molecule drugs for obesity. 'GPCRs have established themselves as very important targets in the obesity and cardiometabolic landscape, but we're at the very early stages of exploration of the target class,' Superluminal CEO Cony D'Cruz told Reuters. Novo struck a $2.2 billion deal with U.S. biotech Septerna in May to develop small-molecule therapies directed at select GPCR targets. Lilly has been capitalizing on the overwhelming popularity of the GLP-1 class of medicines, including its blockbuster drug Zepbound as well as Novo's Wegovy. It is also developing a keenly watched oral GLP-1 drug, orforglipron, which has failed to meet investor expectations. The drugmaker teamed up with Hong Kong-listed biotech Laekna last year to develop an experimental obesity drug that aims to help patients lose weight while preserving muscle. As part of the deal, Superluminal is eligible to receive upfront and milestone payments, an equity investment as well as tiered royalties on net sales, the company said. Boston-based startup Superluminal is developing a wholly owned lead candidate targeting a protein called melanocortin 4 receptor to treat certain rare, genetic forms of obesity and is expected to begin human trials by fourth quarter next year. The lead candidate is not part of the deal with Lilly. Superluminal is backed by investors including RA Capital Management, Insight Partners and NVentures, NVIDIA's venture capital arm. (Reporting by Mariam Sunny in Bengaluru; Editing by Pooja Desai)
